GI262570

· GlaxoSmithKline

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GI262570, covering 2017-12-11 to 2017-12-11. Get the full timeline:

Most recent: Clinical Trial Update: Antifibrotic Activity Of GI262570 In Chronic Hepatitis C Subjects [Phase 2]